Business Description
JD Health International Inc
ISIN : KYG5074A1004
Total Employee Number:
5,263Compare
Compare
Traded in other countries / regions
06618.Hong KongJDHEAL19.Thailand8ZN.GermanyJDHIY.USA IPO Date
2020-12-10Description
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 75.71 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.11 | |||||
Interest Coverage | 354.41 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.11 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.2 | |||||
3-Year EBITDA Growth Rate | 93.8 | |||||
3-Year EPS without NRI Growth Rate | 128.1 | |||||
3-Year FCF Growth Rate | 39 | |||||
3-Year Book Growth Rate | 9.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.88 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 15.98 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 0.01 | |||||
14-Day RSI | 0.3 | |||||
3-1 Month Momentum % | -4.88 | |||||
6-1 Month Momentum % | -22.82 | |||||
12-1 Month Momentum % | 87.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.72 | |||||
Quick Ratio | 2.39 | |||||
Cash Ratio | 2.32 | |||||
Days Inventory | 44.01 | |||||
Days Sales Outstanding | 2.23 | |||||
Days Payable | 81.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -0.32 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 24.78 | |||||
Operating Margin % | 5.36 | |||||
Net Margin % | 7.32 | |||||
EBITDA Margin % | 8.23 | |||||
FCF Margin % | 13.61 | |||||
OCF Margin % | 13.82 | |||||
ROE % | 9.39 | |||||
ROA % | 7.03 | |||||
ROIC % | 16 | |||||
3-Year ROIIC % | 18.08 | |||||
ROC (Joel Greenblatt) % | 609.03 | |||||
ROCE % | 10.44 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.32 | |||||
Forward PE Ratio | 18.99 | |||||
PE Ratio without NRI | 16.91 | |||||
Price-to-Owner-Earnings | 9.88 | |||||
PS Ratio | 1.27 | |||||
PB Ratio | 1.55 | |||||
Price-to-Tangible-Book | 1.6 | |||||
Price-to-Free-Cash-Flow | 9.29 | |||||
Price-to-Operating-Cash-Flow | 9.15 | |||||
EV-to-EBIT | 7.11 | |||||
EV-to-Forward-EBIT | 8.69 | |||||
EV-to-EBITDA | 7.11 | |||||
EV-to-Forward-EBITDA | 8.27 | |||||
EV-to-Revenue | 0.58 | |||||
EV-to-Forward-Revenue | 0.46 | |||||
EV-to-FCF | 4.29 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Projected-FCF | 0.83 | |||||
Price-to-Graham-Number | 1.1 | |||||
| Price-to-Net-Current-Asset-Value | 2.67 | |||||
| Price-to-Net-Cash | 3.48 | |||||
Earnings Yield (Greenblatt) % | 14.06 | |||||
FCF Yield % | 10.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:JDHIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JD Health International Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10,331.551 | ||
| EPS (TTM) ($) | 0.237 | ||
| Beta | 0.5628 | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.19 | ||
| Volatility % | 92.37 | ||
| 14-Day RSI | 0.3 | ||
| 14-Day ATR ($) | 0.001113 | ||
| 20-Day SMA ($) | 5.85 | ||
| 12-1 Month Momentum % | 87.2 | ||
| 52-Week Range ($) | 3.125 - 8.75 | ||
| Shares Outstanding (Mil) | 3,190.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JD Health International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JD Health International Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-08-14 19:00 | In 47 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 46 days | ||
| General meeting for 2025 | 2026-06-29 10:00 | In 1 day | ||
| Annual report for 2025 | 2026-04-24 | 5.85 (-0.85%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-05 20:00 | 6.49 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-05 | 6.49 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-08-14 19:00 | 6.98 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 6.98 (+0.00%) | ||
| General meeting for 2024 | 2025-06-20 10:00 | 3.13 (+0.00%) | ||
| Annual report for 2024 | 2025-04-25 | 3.13 (+0.00%) |
Show
Entries
JD Health International Inc Frequently Asked Questions
What is JD Health International Inc(JDHIF)'s stock price today?
The current price of JDHIF is $5.85. The 52 week high of JDHIF is $8.75 and 52 week low is $3.13.
When is next earnings date of JD Health International Inc(JDHIF)?
The next earnings date of JD Health International Inc(JDHIF) is 2026-08-14 Est..
Does JD Health International Inc(JDHIF) pay dividends? If so, how much?
JD Health International Inc(JDHIF) does not pay dividend.
Guru Commentaries on OTCPK:JDHIF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on JD Health International Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers